Prof Dr Timon van Damme discussed the six-year OS data from the HIMALAYA trial...
Prof Dr Marc Vandeneynde discussed updated results from the BREAKWATER study,...
Five years follow-up data of the CheckMate-648 trial was presented, providing...
In this conversation, Prof Dekervel and Prof Modest discuss recent developments...
The DESTINY-Gastric04 trial is a global phase III study evaluating trastuzumab...
This overview outlines emerging therapeutic developments across...
This summary focuses on the updated results of the phase III Matterhorn trial...
Dr Sheela Rao presented an update on recent advances in the management of...
The CHECKMATE 8HW trial is a pivotal Phase III randomised study evaluating...
The BREAKWATER study represents a major advance in the management of BRAF...